We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Texas Instruments Announces Pricing of Senior Notes Due 2039
Read MoreHide Full Article
Texas Instruments Incorporated (TXN - Free Report) or TI recently announced an offering of senior unsecured notes aggregating $750 million. The notes carry an interest rate of 3.875% and are scheduled to mature on Mar 15, 2039.
The company stated that the transaction proceeds will be used for general corporate purposes.
Barclays Capital, J.P. Morgan Securities, MUFG Securities Americas, Citigroup Global Markets, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Mizuho Securities and Morgan Stanley & Co. are acting as joint book-running managers for the purpose.
Cash Position
At the end of fourth-quarter 2018, its cash and short-term investments totaled $4.2 billion, down from $5.1 billion at the end of the prior quarter. Long-term debt was approximately $4.3 billion, flat sequentially.
The company generated $2.1 billion in cash from operations, spending $323 million on capex, $2 billion on share repurchases and $736 million on cash dividends. Free cash flow at the end of the fourth quarter was $1.8 billion.
We believe that the company has a strong balance sheet, which will help it to capitalize on investment opportunities and pursue strategic acquisitions, further improving growth prospects. In our view, the senior notes’ offering will bring down the company’s cost of capital, in turn strengthening the balance sheet and supporting growth.
These notes should provide financial flexibility as well as propel long-term growth.
Bottom Line
Texas Instruments is one of the largest suppliers of analog and digital signal processing integrated circuits. The company’s compelling product line-up, increasing differentiation in business and low-cost 300mm capacity are anticipated to drive earnings over the long term.
Its margins should continue to expand because of the secular strength in auto and industrial markets, a stronger mix of analog and embedded processing products, benefits of restructuring actions and more than 300mm capacity coming online. Moreover, the semiconductor giant is poised to gain from the growing market for Internet of Things.
However, increasing competition from Analog Devices, NVIDIA Corporation and Applied Materials remains a concern.
Long-term earnings growth rate for Expedia, AMETEK and Inphi is projected to be 13.4%, 9.6% and 18.5%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Texas Instruments Announces Pricing of Senior Notes Due 2039
Texas Instruments Incorporated (TXN - Free Report) or TI recently announced an offering of senior unsecured notes aggregating $750 million. The notes carry an interest rate of 3.875% and are scheduled to mature on Mar 15, 2039.
The company stated that the transaction proceeds will be used for general corporate purposes.
Barclays Capital, J.P. Morgan Securities, MUFG Securities Americas, Citigroup Global Markets, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Mizuho Securities and Morgan Stanley & Co. are acting as joint book-running managers for the purpose.
Cash Position
At the end of fourth-quarter 2018, its cash and short-term investments totaled $4.2 billion, down from $5.1 billion at the end of the prior quarter. Long-term debt was approximately $4.3 billion, flat sequentially.
The company generated $2.1 billion in cash from operations, spending $323 million on capex, $2 billion on share repurchases and $736 million on cash dividends. Free cash flow at the end of the fourth quarter was $1.8 billion.
We believe that the company has a strong balance sheet, which will help it to capitalize on investment opportunities and pursue strategic acquisitions, further improving growth prospects. In our view, the senior notes’ offering will bring down the company’s cost of capital, in turn strengthening the balance sheet and supporting growth.
These notes should provide financial flexibility as well as propel long-term growth.
Bottom Line
Texas Instruments is one of the largest suppliers of analog and digital signal processing integrated circuits. The company’s compelling product line-up, increasing differentiation in business and low-cost 300mm capacity are anticipated to drive earnings over the long term.
Its margins should continue to expand because of the secular strength in auto and industrial markets, a stronger mix of analog and embedded processing products, benefits of restructuring actions and more than 300mm capacity coming online. Moreover, the semiconductor giant is poised to gain from the growing market for Internet of Things.
However, increasing competition from Analog Devices, NVIDIA Corporation and Applied Materials remains a concern.
Zacks Rank and Stocks to Consider
Texas Instruments currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader technology sector include Expedia Group, Inc. (EXPE - Free Report) , AMETEK, Inc. (AME - Free Report) and Inphi Corporation , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Long-term earnings growth rate for Expedia, AMETEK and Inphi is projected to be 13.4%, 9.6% and 18.5%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>